Balyasny Asset Management’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $640K | Sell |
57,032
-547,717
| -91% | -$6.15M | ﹤0.01% | 1496 |
|
|
2025
Q1 | $2.76M | Buy |
604,749
+519,633
| +610% | +$2.37M | ﹤0.01% | 1058 |
|
|
2024
Q4 | $480K | Buy |
85,116
+42,701
| +101% | +$241K | ﹤0.01% | 1487 |
|
|
2024
Q3 | $205K | Sell |
42,415
-46,833
| -52% | -$227K | ﹤0.01% | 1785 |
|
|
2024
Q2 | $436K | Buy |
+89,248
| New | +$436K | ﹤0.01% | 1502 |
|
|
2021
Q3 | – | Sell |
-47,749
| Closed | -$2.88M | – | 2104 |
|
|
2021
Q2 | $2.88M | Buy |
+47,749
| New | +$2.88M | 0.01% | 799 |
|